The effect of exposure to COVID-19 on life satisfaction: The mediating role of hyperarousal and moderating/mediating role of affective forecasting
Journal of Affective Disorders · 2023
DOI: 10.1016/j.jad.2023.05.062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2023. Verfasst von Wei Pan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Adolescent Cyberpsychology and Behavior (CCNU), Ministry of Education, Wuhan 430079, China; School of Psychology, Central China Nor…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Adolescent Cyberpsychology and Behavior (CCNU), Ministry of Education, Wuhan 430079, China; School of Psychology, Central China Normal University, Wuhan 430079, China; Key Laboratory of Human Developme…
Zitieren
APA
Pan, W., Zhou, W., Wu, J., Huang, Z., Ding, L., Guo, L., Hang, B., & Li, X. (2023). The effect of exposure to COVID-19 on life satisfaction: The mediating role of hyperarousal and moderating/mediating role of affective forecasting. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2023.05.062
Vancouver
Pan W, Zhou W, Wu J, Huang Z, Ding L, Guo L, et al. The effect of exposure to COVID-19 on life satisfaction: The mediating role of hyperarousal and moderating/mediating role of affective forecasting. Journal of Affective Disorders. 2023. doi:10.1016/j.jad.2023.05.062
BibTeX
@article{Pan2023,
author = {Pan, Wei and Zhou, Wenwei and Wu, Junjie and Huang, Zhijing and Ding, Linjie and Guo, Liwen and Hang, Bowen and Li, Xu},
title = {The effect of exposure to COVID-19 on life satisfaction: The mediating role of hyperarousal and moderating/mediating role of affective forecasting},
journal = {Journal of Affective Disorders},
year = {2023},
doi = {10.1016/j.jad.2023.05.062}
}
EUVIMED